(AEE) Ameren - Overview
Stock: Electricity, Natural Gas, Transmission
| Risk 5d forecast | |
|---|---|
| Volatility | 17.8% |
| Relative Tail Risk | -1.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 9.81 |
| Character TTM | |
|---|---|
| Beta | 0.185 |
| Beta Downside | 0.236 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.37% |
| CAGR/Max DD | 0.55 |
EPS (Earnings per Share)
Revenue
Description: AEE Ameren February 11, 2026
Ameren Corporation (NYSE:AEE) is a regulated public-utility holding company headquartered in St. Louis, Missouri. It operates four core segments: Ameren Missouri (electric generation, transmission, and distribution), Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission, serving residential, commercial, and industrial customers across Missouri and Illinois.
In its most recent filing (Q4 2025), Ameren reported adjusted earnings of $0.71 per share, a 5 % YoY increase, driven largely by a $210 million rate case approval in Illinois that raised residential electricity rates by 3 % and a modest 2 % growth in natural-gas sales volume. The utility’s generation mix now includes ~23 % renewable capacity (hydro, wind, solar, and methane-gas projects), up from 17 % two years ago, while coal’s share fell to 38 % and nuclear remains steady at 30 % of net generation. Total debt stood at $13.5 billion, with a weighted-average cost of debt of 4.2 % and a debt-to-EBITDA ratio of 4.1×, indicating moderate leverage for a regulated utility.
Key sector drivers include state-level clean-energy mandates (Illinois’ Renewable Portfolio Standard targeting 40 % renewable electricity by 2030) and the broader U.S. utility trend toward decarbonization, which could pressure Ameren’s coal-heavy legacy assets while creating upside for its expanding renewable portfolio. However, any delay in rate case approvals or adverse weather-related demand shocks could materially affect cash-flow stability.
For a deeper, data-driven assessment of Ameren’s valuation and risk profile, the ValueRay analysis offers a concise, model-based perspective worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 2.04 > 1.0 |
| NWC/Revenue: -15.18% < 20% (prev -15.07%; Δ -0.11% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.35b > Net Income 1.46b |
| Net Debt (19.82b) to EBITDA (3.91b): 5.07 < 3 |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.7m) vs 12m ago 1.79% < -2% |
| Gross Margin: 38.14% > 18% (prev 0.48%; Δ 3766 % > 0.5%) |
| Asset Turnover: 18.91% > 50% (prev 17.09%; Δ 1.81% > 0%) |
| Interest Coverage Ratio: 2.94 > 6 (EBITDA TTM 3.91b / Interest Expense TTM 776.0m) |
Altman Z'' 0.66
| A: -0.03 (Total Current Assets 2.57b - Total Current Liabilities 3.91b) / Total Assets 48.48b |
| B: 0.11 (Retained Earnings 5.29b / Total Assets 48.48b) |
| C: 0.05 (EBIT TTM 2.28b / Avg Total Assets 46.54b) |
| D: 0.15 (Book Value of Equity 5.29b / Total Liabilities 34.95b) |
| Altman-Z'' Score: 0.66 = B |
Beneish M -2.67
| DSRI: 1.06 (Receivables 1.19b/967.0m, Revenue 8.80b/7.62b) |
| GMI: 1.26 (GM 38.14% / 47.92%) |
| AQI: 1.01 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.15 (Revenue 8.80b / 7.62b) |
| TATA: -0.04 (NI 1.46b - CFO 3.35b) / TA 48.48b) |
| Beneish M-Score: -2.67 (Cap -4..+1) = A |
What is the price of AEE shares?
Over the past week, the price has changed by -0.83%, over one month by +6.09%, over three months by +7.14% and over the past year by +16.53%.
Is AEE a buy, sell or hold?
- StrongBuy: 8
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the AEE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.4 | 4.8% |
| Analysts Target Price | 115.4 | 4.8% |
AEE Fundamental Data Overview February 22, 2026
P/E Forward = 19.305
P/S = 3.5912
P/B = 2.3747
P/EG = 2.3957
Revenue TTM = 8.80b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 3.91b USD
Long Term Debt = 18.21b USD (from longTermDebt, last quarter)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 19.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.82b USD (from netDebt column, last quarter)
Enterprise Value = 50.23b USD (30.42b + Debt 19.83b - CCE 13.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 2.28b / Interest Expense TTM 776.0m)
EV/FCF = -62.72x (Enterprise Value 50.23b / FCF TTM -801.0m)
FCF Yield = -1.59% (FCF TTM -801.0m / Enterprise Value 50.23b)
FCF Margin = -9.10% (FCF TTM -801.0m / Revenue TTM 8.80b)
Net Margin = 16.55% (Net Income TTM 1.46b / Revenue TTM 8.80b)
Gross Margin = 38.14% ((Revenue TTM 8.80b - Cost of Revenue TTM 5.44b) / Revenue TTM)
Gross Margin QoQ = 27.95% (prev 36.64%)
Tobins Q-Ratio = 1.04 (Enterprise Value 50.23b / Total Assets 48.48b)
Interest Expense / Debt = 1.04% (Interest Expense 206.0m / Debt 19.83b)
Taxrate = 8.52% (136.0m / 1.60b)
NOPAT = 2.09b (EBIT 2.28b * (1 - 8.52%))
Current Ratio = 0.66 (Total Current Assets 2.57b / Total Current Liabilities 3.91b)
Debt / Equity = 1.48 (Debt 19.83b / totalStockholderEquity, last quarter 13.40b)
Debt / EBITDA = 5.07 (Net Debt 19.82b / EBITDA 3.91b)
Debt / FCF = -24.74 (negative FCF - burning cash) (Net Debt 19.82b / FCF TTM -801.0m)
Total Stockholder Equity = 12.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 1.46b / Total Assets 48.48b)
RoE = 11.48% (Net Income TTM 1.46b / Total Stockholder Equity 12.68b)
RoCE = 7.39% (EBIT 2.28b / Capital Employed (Equity 12.68b + L.T.Debt 18.21b))
RoIC = 6.46% (NOPAT 2.09b / Invested Capital 32.34b)
WACC = 4.37% (E(30.42b)/V(50.25b) * Re(6.60%) + D(19.83b)/V(50.25b) * Rd(1.04%) * (1-Tc(0.09)))
Discount Rate = 6.60% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.82%
Fair Price DCF = unknown (Cash Flow -801.0m)
EPS Correlation: 21.73 | EPS CAGR: -1.40% | SUE: 0.99 | # QB: 2
Revenue Correlation: 25.85 | Revenue CAGR: -1.40% | SUE: 0.85 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.07 | Chg30d=+0.001 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=5.38 | Chg30d=+0.009 | Revisions Net=+2 | Growth EPS=+0.5% | Growth Revenue=+2.8%
EPS next Year (2027-12-31): EPS=5.87 | Chg30d=+0.077 | Revisions Net=+3 | Growth EPS=+9.1% | Growth Revenue=+7.0%